Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 8Terminated 2Recruiting 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Fatigue 1Breast Neoplasms 1

Interventions

Cyclophosphamide 390Carboplatin 344Gemcitabine 332pembrolizumab 329Cisplatin 328Paclitaxel 297Radiotherapy 296Docetaxel 286Bevacizumab 253Rituximab 234Capecitabine 223Nivolumab 220Dexamethasone 206Fluorouracil 190fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 133Cetuximab 129Bortezomib 129fludarabine phosphate 128Lenalidomide 126Erlotinib Hydrochloride 120Filgrastim 119Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Dextromethorphan × Clear all
NCT00873366 2018-01-23

Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer

Mayo Clinic

Terminated
92 enrolled 20 charts
Breast

Breast Neoplasms

NCT00176540 2011-05-17

Dextromethorphan in Treating Patients With Fatigue Caused by Cancer

Rutgers, The State University of New Jersey

Phase NA Terminated
30 enrolled

Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡